These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35190406)

  • 1. Efficacy of umbilical cord mesenchymal stem cell transfusion for the treatment of severe AKI: a protocol for a randomised controlled trial.
    Yang Y; Gao J; Wang S; Wang W; Zhu FL; Wang X; Liang S; Feng Z; Lin S; Zhang L; Chen X; Cai G
    BMJ Open; 2022 Feb; 12(2):e047622. PubMed ID: 35190406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human umbilical cord mesenchymal stem cell transplantation for the treatment of acute-on-chronic liver failure: protocol for a multicentre random double-blind placebo-controlled trial.
    Wang Y; Li M; Yang T; Xie Y; Wang FS; Hu J; Shi M
    BMJ Open; 2024 Jun; 14(6):e084237. PubMed ID: 38925694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
    Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
    Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cell therapy in acute kidney injury (AKI): review and perspectives.
    Sávio-Silva C; Soinski-Sousa PE; Balby-Rocha MTA; Lira ÁO; Rangel ÉB
    Rev Assoc Med Bras (1992); 2020 Jan; 66Suppl 1(Suppl 1):s45-s54. PubMed ID: 31939535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of human umbilical cord mesenchymal stem cells for the treatment of sepsis induced by pneumonia: study protocol for a single-centre, randomised single-blind parallel group trial.
    Wang C; Zhao D; Zheng L; Bao X; Yang Q; Jiang S; Zhou X; Tang L; Liu Z
    BMJ Open; 2022 Apr; 12(4):e058444. PubMed ID: 35379638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human umbilical cord mesenchymal stem cell therapy for renal dysfunction in Alport syndrome: protocol for an open-label, single-arm trial in China.
    Huang L; Zou J; Zhang Y; Gu J; Wu J; Zhang C
    BMJ Open; 2024 Mar; 14(3):e075138. PubMed ID: 38490657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of combination of vitamin E and umbilical cord-derived mesenchymal stem cells on inflammation in mice with acute kidney injury.
    Guo Q; Wang J
    Immunopharmacol Immunotoxicol; 2018 Apr; 40(2):168-172. PubMed ID: 29355065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
    Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
    Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current understanding of the administration of mesenchymal stem cells in acute kidney injury to chronic kidney disease transition: a review with a focus on preclinical models.
    Zhao L; Han F; Wang J; Chen J
    Stem Cell Res Ther; 2019 Dec; 10(1):385. PubMed ID: 31843011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal Stem Cells: a Promising Therapeutic Tool for Acute Kidney Injury.
    Selim RE; Ahmed HH; Abd-Allah SH; Sabry GM; Hassan RE; Khalil WKB; Abouhashem NS
    Appl Biochem Biotechnol; 2019 Sep; 189(1):284-304. PubMed ID: 30976980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Beneficial Effects of Mesenchymal Stem Cells in Acute Kidney Injury: A Narrative Review.
    Liu Y; Han J; Fang J; Li R
    Curr Stem Cell Res Ther; 2024; 19(2):200-209. PubMed ID: 36748221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal Stem Cells in Kidney Repair.
    Morigi M; Rota C; Remuzzi G
    Methods Mol Biol; 2016; 1416():89-107. PubMed ID: 27236667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preconditioning strategies for improving the survival rate and paracrine ability of mesenchymal stem cells in acute kidney injury.
    Zhao L; Hu C; Zhang P; Jiang H; Chen J
    J Cell Mol Med; 2019 Feb; 23(2):720-730. PubMed ID: 30484934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renoprotective effect of human umbilical cord-derived mesenchymal stem cells in immunodeficient mice suffering from acute kidney injury.
    Fang TC; Pang CY; Chiu SC; Ding DC; Tsai RK
    PLoS One; 2012; 7(9):e46504. PubMed ID: 23029541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the treatment efficacy of umbilical mesenchymal stem cell transplantation via renal subcapsular and parenchymal routes in AKI-CKD mice.
    Huang M; Li D; Chen J; Ji Y; Su T; Chen Y; Zhang Y; Wang Y; Li F; Chen S; Dong Y; Li Q; Wu L; Feng Z; Wu J; Zhang L; Li Z; Cai G; Chen X
    Stem Cell Res Ther; 2022 Mar; 13(1):128. PubMed ID: 35337372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory Effects of Mesenchymal Stem Cells on Drug-Induced Acute Kidney Injury.
    Han Q; Wang X; Ding X; He J; Cai G; Zhu H
    Front Immunol; 2021; 12():683003. PubMed ID: 34149721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic human umbilical cord-derived mesenchymal stem cells for severe bronchopulmonary dysplasia in children: study protocol for a randomized controlled trial (MSC-BPD trial).
    Wu X; Xia Y; Zhou O; Song Y; Zhang X; Tian D; Li Q; Shu C; Liu E; Yuan X; He L; Liu C; Li J; Liang X; Yang K; Fu Z; Zou L; Bao L; Dai J
    Trials; 2020 Jan; 21(1):125. PubMed ID: 32005282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulsed focused ultrasound pretreatment improves mesenchymal stromal cell efficacy in preventing and rescuing established acute kidney injury in mice.
    Burks SR; Nguyen BA; Tebebi PA; Kim SJ; Bresler MN; Ziadloo A; Street JM; Yuen PS; Star RA; Frank JA
    Stem Cells; 2015 Apr; 33(4):1241-53. PubMed ID: 25640064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene-modified Mesenchymal Stem Cell-based Therapy in Renal Ischemia- Reperfusion Injury.
    Xu H; Chen C; Hu L; Hou J
    Curr Gene Ther; 2017; 17(6):453-460. PubMed ID: 29446737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.